KinoPharma
Business Services · Japan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5-25-16 Hongo Bunkyo-ku, Tokyo, Tokyo, J...Phone Number
+81 352999711Website
www.kinopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About KinoPharma
KinoPharma is a next-generation antiviral drug development company focused on creating new antiviral medications for diseases caused by human papillomavirus (HPV), particularly cervical cancer. The company aims to provide innovative treatments to patients worldwide as quickly as possible, utilizing novel drug discovery strategies. They are actively engaged in research and development, including clinical trials for their products. Their target clients include patients suffering from HPV-related conditions and healthcare providers seeking effective antiviral therapies.Explore more
Popular SearchesKinoPharma IncKinopharma KKKinoPharmaSIC Code 87,873NAICS Code 54,541Show moreKinoPharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is KinoPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at KinoPharma
Click to see if KinoPharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
KinoPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on KinoPharma recently announced quarterly report
Check out if KinoPharma is spiking on competitors!
Product Launch: Get notified when KinoPharma launches new products
Check if KinoPharma has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once KinoPharma has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
KinoPharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
KinoPharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about KinoPharma.
KinoPharma Tech Stack
A closer look at the technologies used by KinoPharma
KinoPharma News & Media
ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc. Enter into Option Agreement for Treatment of Cervical Dysplasia
ASKA Pharmaceutical Co., Ltd. (hereinafter "ASKA") and KinoPharma, Inc. (hereinafter "KinoPharma"), both based in Tokyo, announced on January 14 that they have entered into an option agreement for an exclusive license for the development and commercialization of a candidate drug for cervical dysplasia under preclinical development by KinoPharma.KinoPharma and National Institutes for Quantum and Radiological Science and Technology Launch Collaborative Research Project for Exploring New Drug Development for Alzheimer's Disease
TOKYO, Aug. 29, 2018 /PRNewswire/ -- KinoPharma, Inc., and the National Institutes for Quantum and Radiological Science and Technology are pleased to announce that they have entered a contract for collaborative research on efficacy evaluation of the compound KPO1143, developed by...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding KinoPharma
Sign Up For FreeTo access detailed company insights
KinoPharma is a next-generation antiviral drug development company focused on creating new antiviral medications for diseases caused by human papillomavirus (HPV), particularly cervical cancer. The company aims to provide innovative treatments to patients worldwide as quickly as possible, utilizing novel drug discovery strategies. They are actively... Read More
